Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma

M.D. Anderson Cancer Center · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
hematopoietic and lymphoid cell neoplasm, recurrent diffuse large b-cell lymphoma, recurrent high grade b-cell lymphoma, recurrent primary mediastinal (thymic) large b-cell lymphoma, recurrent transformed follicular lymphoma to diffuse large b-cell lymphoma, refractory diffuse large b-cell lymphoma, refractory high grade b-cell lymphoma, refractory primary mediastinal (thymic) large b-cell lymphoma, refractory transformed follicular lymphoma to diffuse large b-cell lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 831176
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.